Related Experiment Video
Updated: May 4, 2026

Developing a Rat Model for Bipolar Disorder
Published on: May 2, 2025
Emerging drugs for bipolar depression: an update.
Paul A Keedwell1, Allan H Young
1Neuroscience and Mental Health Research Institute , Hadyn Ellis Building, Maindy Road, Cardiff CF24 4HQ , UK.
Treating bipolar depression is challenging, as traditional antidepressants are often ineffective and can trigger mania. Novel agents targeting specific pathways show promise for better outcomes and reduced side effects.
Area of Science:
- Psychiatry
- Pharmacology
Background:
- Acute management of bipolar depression is challenging.
- Traditional antidepressants show poor response rates and can induce mania or rapid cycling.
- Bipolar depression requires novel therapeutic strategies.
Purpose of the Study:
- Review evidence for existing and emerging pharmacological treatments for bipolar depression.
- Evaluate response, remission rates, and risk of mania switching.
- Consider novel mechanisms of action and future strategies.
Main Methods:
- Systematic review of pharmacological treatments for bipolar depression.
- Analysis of efficacy, tolerability, and safety profiles.
- Consideration of novel drug classes and future research directions.
Main Results:
- Traditional antidepressants have limited efficacy and carry risks in bipolar depression.
- Emerging agents like NMDA antagonists and adjunctive dopaminergics show promise.
- Dual-action antidepressants may offer efficacy but require further study on switching risk.
Conclusions:
- There is a need for more effective, tolerable, and faster-acting treatments for bipolar depression.
- Novel pharmacological agents targeting specific neurotransmitter systems offer potential.
- Further randomized controlled trials and naturalistic studies are essential to guide treatment.
More Related Videos
07:05Behavioral Disturbances: An Innovative Approach to Monitor the Modulatory Effects of a Nutraceutical Diet
Published on: January 3, 2017
08:15Network Pharmacology and Validation of the Antidepressant Mechanisms of Qiangzhifang in a Chronic Restraint Stress-induced Depression Rat Model
Published on: June 6, 2025
Related Concept Videos
Antidepressant Drugs: MAOIs and Other Agents
Mania and Antimanic Drugs: Overview
Drug Therapy
Antianxiety Medications
Antidepressant Drugs: Overview
Bipolar Disorder
Antidepressant Drugs: Tricyclics, SSRIs, and SNRIs